TABLE 3.

Univariate and multivariate analysis of variables predicting clinical cure.

Overall cohort (n = 56, clinical cure = 33)
	Clinical cure (N = 33)	Non-clinical cure (N = 23)	Unadjusted OR (95% CI)	p-value	Adjusted OR (95% CI)	p-value
Age	73.85 (±12.01)	72.51 (±13.38)	0.97 (0.92–1.03)	0.36	0.98 (0.93–1.03)	0.49
Male	13 (39.4)	12 (52.2)	0.72 (0.19–2.73)	0.63
CHARLSON index	6.06 (±2.77)	4.96 (±2.69)	1.36 (0.97–1.92)	0.07	1.30 (0.97–1.75)	0.08
Pulmonary disease	11 (33.3)	8 (34.8)	0.57 (0.12–2.79)	0.49
Chronic kidney disease	5 (15.2)	5 (21.7)	0.17 (0.02–1.28)	0.09	0.24 (0.042–1.43)	0.12
Desensitization	10 (30.3)	4 (17.4)	0.38 (0.07–2.21)	0.28	0.54 (0.11–2.62)	0.45
Post-surgical infection	13 (39.4)	8 (34.8)	1.58 (0.36–6.88)	0.54
Bloodstream infection	19 (57.6)	13 (56.5)	1.30 (0.30–5.60)	0.72
QuickSOFA	0.70 (±0.81)	1.22 (±1.08)	0.42 (0.19–0.89)	0.02	0.47 (0.24–0.92)	0.03
Polymicrobial	10 (30.3)	7 (30.4)	0.77 (0.14–4.19)	0.76
MDR microorganisms	11 (33.3)	9 (39.1)	0.45 (0.09–2.23)	0.33

Data are presented as n (%), unless otherwise specified. OR: odds ratio, CI: confidence interval. quickSOFA: quick Sequential Organ Failure Assessment. MDR: multidrug-resistant. Statistical significance at p < 0.05.